Department of Biochemistry and Molecular Biology Center for Cellular and Molecular Diagnosis, School of Medicine, Tulane University, New Orleans, LA, USA.
Department of Biochemistry and Molecular Biology, Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA.
Trends Cancer. 2021 Feb;7(2):122-133. doi: 10.1016/j.trecan.2020.09.003. Epub 2020 Sep 30.
Early cancer diagnosis is critical for improving patient survival and mortality rates, but most diagnostics on solid tumors rely on imaging tests with limited sensitivity and specificity to identify potential cases, which are then confirmed by tissue biopsies. However, this process is usually not suitable for cancer screening or evaluation of tumor responses to treatment. Liquid biopsies have the potential to bridge this gap, but few such assays have been approved for cancer applications. Extracellular vesicles hold particular promise for liquid biopsy diagnostics but are currently limited by the lack of robust methods for isolation and analysis. New isolation and analysis techniques, however, show promise to improve the clinical utility of extracellular vesicle-based cancer diagnosis.
早期癌症诊断对于提高患者生存率和死亡率至关重要,但大多数实体瘤的诊断依赖于成像测试,其敏感性和特异性有限,难以识别潜在病例,然后通过组织活检进行确认。然而,这个过程通常不适用于癌症筛查或评估肿瘤对治疗的反应。液体活检有潜力弥补这一差距,但目前很少有此类检测方法被批准用于癌症应用。细胞外囊泡在液体活检诊断方面具有特别的应用前景,但目前受到缺乏可靠的分离和分析方法的限制。然而,新的分离和分析技术有望提高基于细胞外囊泡的癌症诊断的临床实用性。